NECLIFE — Nectar Lifesciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹2.00bn
- IN₹85.94m
- IN₹20.11m
Annual cashflow statement for Nectar Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 341 | -424 | 183 | -1,615 | -7,889 |
| Depreciation | |||||
| Non-Cash Items | 685 | 390 | 768 | 766 | 2,114 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -645 | 779 | 689 | 1,920 | 2,059 |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 950 | 1,337 | 2,247 | 1,694 | -3,487 |
| Capital Expenditures | -250 | -301 | -294 | -438 | -123 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 416 | 818 | 124 | 18.6 | 12,204 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 166 | 517 | -170 | -419 | 12,081 |
| Financing Cash Flow Items | -788 | -795 | -871 | -746 | -1,845 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,194 | -1,856 | -2,054 | -1,281 | -7,665 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -77.3 | -2.28 | 22.3 | -5.84 | 929 |